Vitamin D status and cardiovascular health: A 2009 update

Open Clinical Chemistry Journal

Volumn 3, Issue SPEC. ISSUE 1, 2010, Pages 51-59

  Michos, Erin D ^a   Reis, Jared P ^b   Melamed, Michal L ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease risk; Review; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN; C REACTIVE PROTEIN; CALCIUM; ROSUVASTATIN; TRIACYLGLYCEROL; VITAMIN D; VITAMIN D RECEPTOR;

ARTERY CALCIFICATION; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RECOMMENDED DRUG DOSE; RISK FACTOR; STROKE; SUN EXPOSURE; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 78249240909     PISSN: None     EISSN: 18742416     Source Type: Journal    
DOI: 10.2174/1874241601003020051     Document Type: Article

References (99)

1. th ed. Emery, A.E.; Rimoin, D.; Eds.; Churchill Livingston: New York 2002; pp. 2566-2623.
2. Spina, C.S.; Tangpricha, V.; Uskokovic, M.; Adorinic, L.; Maehr, H.; Holick, M.F. Vitamin D and cancer. Anticancer Res., 2006, 26(4A), 2515-2524.
3. Yamshchikov, A.V.; Desai, N.S.; Blumberg, H.M.; Ziegler, T.R.; Tangpricha, V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized clinical trials. Endocr. Pract., 2009, 15(5), 438-449.
4. Szodoray, P.; Nakken, B.; Gaal, J.; Jonsson, R.; Szegedi, A.; Zold, E.; Szegedi, G.; Brun, J.G.; Gesztelyi, R.; Zeher, M.; Bodolay, E. The complex role of vitamin D in autoimmune diseases. Scan. J. Immunol., 2008, 68(3), 261-269.
5. Agarwal, R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin. J. Am. Soc. Nephrol., 2009, 4, 1523-1528.
6. Zitterman, A; Schleithoff, S.S.; Koerfer, R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr., 2005, 94, 483-492.
7. Lee, J.H.; O'Keefe, J.H.; Bell, D.; Hensrud, D.D.; Holick, M.F. Vitamin D deficiency: An important, common, and easily treatable cardiovascular risk factor. J. Am. Coll. Cardiol., 2008, 52, 1949-1956.
8. Lim, H.S.; Roychoudhuri, R.; Peto, J.; Schwartz, G.; Baade, P.; Moller, H. Cancer survival is dependent on season of diagnosis and sunlight exposure. Int. J. Cancer, 2006, 119(7), 1530-1536.
9. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med., 2007, 357, 266-281.
10. Holick, M.F.; Chen, T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr., 2008, 87 (suppl), 1080-1086.
11. Hewison, M.; Burke, F.; Evans, K.N.; Lammas, D.A.; Sansom, D.M.; Liu, P.; Modlin, R.L.; Adams, J.S. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 316-321.
12. Dawson-Hughes, B.; Heaney, R.P.; Holick, M.F.; Lips, P.; Meunier, P.J.; Vieth, R. Estimates of optimal vitamin D status. Osteoporos. Int., 2005, 16, 713-716.
13. Zadshir, A.; Tareen, N; Pan, D.; Norris, K.; Martins, D. The prevalence of hypovitaminosis D among US adults: data from NHANES III. Ethn. Dis., 2005, 15(S5), 97-101.
14. Ginde, A.A.; Liu, M.C.; Camargo, C.A. Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med., 2009, 169(6), 626-632.
15. Looker, A.C.; Pfeiffer, C.M.; Lacher, D.A.; Schleicher, R.L.; Picciano, M.F.; Yetley, E.A. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am. J. Clin. Nutr., 2008, 88(6), 1519-1527.
16. Looker, A.C.; Lacher, D.A.; Pfeiffer, C.M.; Schleicher, R.L.; Picciano, M.F.; Yetley, E.A. Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. Am. J. Clin. Nutr., 2009, 90(3), 695.
17. Martins, D.; Wolf, M.; Pan, D.; Zadshir, A.; Tareen, N.; Thadhani, R.; Felsenfeld, A.; Levine, B.; Mehrotra, R.; Norris, K. Prevalence of cardiovascular risk factors and the serum levels of 25hydroxyvitamin D in the United States: Data from the third national health and nutrition examination survey. Arch. Intern. Med., 2007, 167(11), 1159-1165.
18. Scragg, R.; Camargo, C.A. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: Results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol., 2008, 168, 577-586.
19. Forman, J.P.; Bischoff-Ferrari, H.A.; Willett, W.C.; Stampfer, M.J., Curhan, G.C. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension, 2005, 46(4), 676-682.
20. Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25hydroxyvitamin D levels and the risk of incident hypertension. Hypertension, 2007, 49, 1063-1069.
21. Scragg, R.; Sower, M.; Bell, C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens., 2007, 20(7), 713-719.
22. Schmitz, K.J.; Skinner, H.G.; Bautista, L.E.; Fingerlin, T.E.; Langefeld, C.D.; Hicks, P.J.; Haffner, S.M.; Bryer-Ash, M.; Wagenknecht, L.E., Bowden, D.W.; Norris, J.M.; Engelman, C.D. Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am. J. Hypertens., 2009, 22(8), 867-870.
23. Li, Y.C.; Kong, J.; Wei, M; Chen, Z.F.; Liu, S.Q.; Cao, L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest., 2002, 110(2), 229-238.
24. Xiang, W.; Kong, J.; Chen, S.; Cao, L.P.; Qiao, G.; Zheng, W.; Liu, W.; Li, X.; Gardner, D.G.; Li, Y.C. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac reninangiotensin systems. Am. J. Physiol. Endocrinol. Metab., 2005, 288(1), E125-132.
25. Zhou, C.; Lu, F.; Cao, K.; Xu, D.; Goltzman, D; Miao, D. Calciumindependent and 1,25(OH)2D3-dependent regulation of the renninangiotensin system in 1 -hydroxylase knockout mice. Kidney Int., 2008, 74, 170-179.
26. Krause, R.; Buhring, M.; Hopfenmuller, W.; Holick, M.F., Sharma, A.M. Ultraviolet B and blood pressure. Lancet, 1998, 352(9129), 709-710.
27. Pfeifer, M.; Begerow, B.; Minne, H.W.; Nachtigall, D.; Hansen, C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab., 2001, 86(4), 1633-1637.
28. Sugden, J.A.; Davies, J.I.; Witham, M.D.; Morris, A.D.; Struthers, A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet. Med., 2008, 25(3), 320-325.
29. Ford, E.S.; Ajani, U.A.; McGuire, L.C.; Liu, S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care, 2005, 28, 1228-1230.
30. Baynes, K.C.; Boucher, B.J.; Feskens, E.J.; Kromhout, D. Vitamin D, glucose intolerance, and insulinemia in elderly men. Diabetologia, 1997, 40, 344-347.
31. Melamed, M.L.; Michos, E.D.; Post, W.; Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med., 2008, 168(15), 1629-1637.
32. Caan, B.; Neuhouser, M.; Aragaki, A.; Lewis, C.B.; Jackson, R.; LeBoff, M.S.; Margolis, K.L.; Powell, L.; Uwaifo, G.; Whitlock, E.; Wylie-Rosett, J.; LaCroix, A. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch. Intern. Med., 2007, 167(9), 893-902.
33. Knekt, P.; Laaksonen, M.; Mattila, C.; Härkänen, T.; Marniemi, J.; Heliövaara, M.; Rissanen, H.; Montonen, J.; Reunanen, A. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology, 2008, 19, 666-671.
34. Forouhi, N.G.; Luan, J.; Cooper, A.; Boucher, B.J.; Wareham, N.J. Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes, 2008, 57(10), 2619-2625.
35. Mathieu, C.; Gysemans, G.; Giulietti, A.; Bouillon, R. Vitamin D and diabetes. Diabetologia, 2005, 48, 1247-1257.
36. Chiu, K.C.; Chu, A.; Go, V.L.; Saad, M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr., 2004, 79, 820-825.
37. Scragg, R. Vitamin D and type 2 diabetes: are we ready for a prevention trial? Diabetes, 2008, 57, 2565-2566.
38. Hypponen, E.; Laara, E.; Reunanen, A.; Jarvelin, M.R.; Virtanen, S.M. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet, 2001, 358(9292), 1500-1503.
39. Pittas, A.G.; Dawson-Hughes, B., Li, T.; Van Dam, R.M.; Willett, W.C., Manson, J.E., Hu, F.B. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care, 2006, 26(3), 650-656.
40. de Boer, I.H.; Tinker, L.F.; Connelly, S.; Curb, J.D.; Howard, B.V.; Kestenbaum, B.; Larson, J.C.; Manson, J.E.; Margolis, K.L.; Siscovick, D.S.; Weiss, N.S. Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care, 2008, 31, 701-797.
41. Perez-Castrillon, J.L.; Vega, G.; Abad, L.; Sanz, A.; Chaves, J.; Hernandez, G.; Duenas, A. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am. J. Cardiol., 2007, 99(7), 903-905.
42. Yavuz, B.; Ertugrul, D.T.; Cil, H.; Ata, N.; Akin, K.O.; Yalcin, A.A.; Kucukazman, M.; Dal, K.; Hokkaomeroglu, M.S.; Yavuz, B.B.; Tutal, E. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc. Drug Ther., 2009, 23(4), 295-299.
43. Garrett, I.R.; Gutierrez, G.; Mundy, G.R. Statins and bone formation. Curr. Pharm. Des., 2001, 7, 715-736.
44. Wang, P.S.; Solomon, D.H.; Mogun, H.; Avorn, J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA, 2000, 382, 3211-3216.
45. Rejnmark, L.; Olsen, M.L.; Johnsen, S.P.; Vestergaard, P.; Sørensen, H.T.; Mosekilde L. Hip fracture risk in statin users-a population based Danish case-control study. Osteoporos. Int., 2004, 15, 452-458.
46. Dawson-Hughes, B.; Harris, S.S.; Krall, E.A.; Dallal, G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med., 1997, 337(10), 670-6.
47. Grimes, D.S. Are statins analogues of vitamin D? Lancet, 2006, 368, 83-86.
48. Mathieu, C.; Adorini, L. The coming of age of 1,25 dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med., 2002, 8, 174-178.
49. Banerjee, P.; Chatterjee, M. Antiproliferative role of vitamin D and its analogs--a brief overview. Mol Cell Biochem., 2003, 253(1-2), 247-254.
50. Timms, P.M.; Mannan, N.; Hitman, G.A.; Noonan, K.; Mills, P.G.; Syndercombe-Court, D.; Aganna, E.; Price, C.P.; Boucher, B.J. Circulating MMP9, vitamin D, and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM, 2002, 95, 787-796.
51. Van den Berghe, G.; Van Roosbroeck, D.; Vanhove, P.; Wouters, P.J.; De Pourcq, L.; Bouillon, R. Bone turnover in prolonged critical illness: effect of vitamin D. J. Clin. Endocrinol. Metab., 2003, 88, 4623-4632.
52. Alborzi, P.; Patel, N.A.; Peterson, C.; Bills, J.E.; Bekele, D.M.; Bunaye, Z.; Light, R.P.; Agarwal, R. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension, 2008, 52(2), 249-255.
53. Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a doubleblind, randomized, placebo-controlled trial. Am. J. Clin. Nutr., 2006, 83(4), 754-759.
54. Michos, E.D.; Streeten, E.A.; Ryan, K.A.; Rampersaud, E.; Peyser, P.A.; Bielak, L.F.; Shuldiner, A.R.; Mitchell, B.D.; Post, W. Serum 25-hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the Old Order Amish. Calcific Tissue Int., 2009, 84(3), 195-202.
55. Teng, M.; Wolf, M.; Ofsthun, M.N.; Lazarus, J.M.; Hernán, M.A.; Camargo, C.A. Jr; Thadhani, R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J. Am. Soc. Nephrol., 2005, 16(4), 1115-1125.
56. Melamed, M.L.; Eustace, J.A.; Plantinga, L.; Jaar, B.G.; Fink, N.E.; Coresh, J.; Klag, M.J.; Powe, N.R. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int., 2006, 70(2), 351-357.
57. Tentori, F.; Hunt, W.C.; Stidley, C.A.; Rohrscheib, M.R.; Bedrick, E.J.; Meyer, K.B.; Johnson, H.K.; Zager, P.G.; Medical Directors of Dialysis Clinic Inc. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int., 2006, 70(10), 1858-1865.
58. Makibayashi, K.; Tatematsu, M.; Hirata, M.; Fukushima, N.; Kusano, K.; Ohashi, S.; Abe, H.; Kuze, K.; Fukatsu, A.; Kita, T.; Doi, T. A vitamin d analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol., 2001, 158, 1733-1741.
59. Aschenbrenner, J.K.; Sollinger, H.W.; Becker, B.N.; Hullett, D.A. 1,25-(oh(2))d(3) alters the transforming growth factor beta signaling pathway in renal tissue. J. Surg. Res., 2001, 100, 171-175.
60. Migliori, M.; Giovannini, L.; Panichi, V.; Filippi, C.; Taccola, D.; Origlia, N.; Mannari, C.; Camussi, G. Treatment with 1,25dihydroxyvitamin d3 preserves glomerular slit diaphragmassociated protein expression in experimental glomerulonephritis. Int. J. Immunopathol. Pharmacol., 2005, 18, 779-790.
61. Szeto, C.C.; Chow, K.M.; Kwan, B.C.; Chung, K.Y.; Leung, C.B.; Li, P.K. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am. J. Kidney Dis., 2008, 51, 724-731.
62. Agarwal, R.; Acharya, M.; Tian, J.; Hippensteel, R.L.; Melnick, J.Z.; Qiu, P.; Williams, L.; Batlle, D. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int., 2005, 68(6), 2823-2838.
63. de Boer, I.H.; Ioannou, G.N.; Kestenbaum, B.; Brunzell, J.D.; Weiss, N.S. 25-hydroxyvitamin d levels and albuminuria in the third national health and nutrition examination survey (NHANES III). Am. J. Kidney Dis., 2007, 50, 69-77.
64. Lambers, H.H.J.; Agarwal, R.; Coyne, D.W.; Parving, H.H.; Ritz, E.; Remuzzi, G.; Audhya, P.; Amdahl, M.J.; Andress, D.L.; de Zeeuw, D. The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics. Am. J. Nephrol., 2009, 30(3), 280-286.
65. Fleckenstein-Grun, G.; Thimm, F.; Frey, M.; Matyas, S. Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats. J. Cardiovasc. Pharmacol., 1995, 26, 207-13.
66. Zittermann, A.; Schleithoff, S.S.; Koerfer, R. Vitamin D and vascular calcification. Curr. Opin. Lipidol., 2007, 18, 41-46.
67. Watson, K.E.; Abrolat, M.L.; Malone, L.L., Hoeg, J.M.; Doherty, T.; Detrano, R.; Demer, L.L. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation, 1997, 96, 1755-1760.
68. Doherty, T.M.; Tang, W.; Dascalos, S.; Watson, K.E.; Demer, L.L.; Shavelle, R.M.; Detrano, R.C. Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation, 1997, 96, 1477-1481.
69. Arad, Y.; Spadaro, L.A.; Roth, M.; Scordo, J.; Goodman, K.; Sherman, S.; Lerner, G.; Newstein, D.; Guerci, A.D. Serum concentration of calcium, 1, 25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis., 1998, 9, 513-518.
70. de Boer, I.H.; Kestenbaum, B.; Shoben, A.B.; Michos, E.D.; Sarnak, M.J.; Siscovick, D.S. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcium. J. Am. Soc. Nephrol., 2009, 20(8), 1805-1812.
71. Targher, G.; Bertolini, L.; Padovani, R.; Zenari, L.; Scala, L.; Cigolini, M.; Arcaro, G. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol., 2006, 65, 593-597.
72. Reis, J.P.; von Muhlen, D.; Michos, E.D.; Miller III E.R.; Appel, L.J.; Araneta, M.R.; Barrett-Connor, E. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis, 2009, 207(2), 585-590.
73. Melamed, M.L.; Muntner, P.; Michos, E.D.; Uribarri, J.; Weber, C.; Sharma, J.; Raggi, P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1179-1185.
74. Reis, J.P.; Michos, E.D.; von Muhlen, D.; Miller, E.R. 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am. J. Clin. Nutr., 2008, 88(6), 1569-1577.
75. Park, C.W.; Oh, Y.S.; Shin, Y.S.; Kim, C.M.; Kim, Y.S.; Kim, S.Y.; Choi, E.J.; Chang Y.S.; Bang, B.K. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am. J. Kidney Dis., 1999, 33(1), 73-81.
76. Kim, H.W.; Park, C.W.; Shin, Y.S.; Kim, Y.S.; Shin, S.J.; Choi, E.J.; Chang, Y.S.; Bang, B.K. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin. Pract., 2006, 102(1), c21-29.
77. Scragg, R.; Jackson, R.; Holdaway, I.M.; Lim, T.; Beaglehole, R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int. J. Epidemiol., 1990, 19, 559-563.
78. Giovannucci, E.; Liu, Y.; Hollis, B.W.; Rimm, E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch. Intern. Med., 2008, 168, 1174-1180.
79. Rajasree, S.; Rajpal, K.; Kartha, C.C.; Sarma, P.S.; Kutty, V.R.; Iyer, C.S.; Girija, G. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur. J. Epidemiol., 2001, 17, 567-571.
80. Poole, K.E.; Loveridge, N.; Barker, P.J.; Halsall, D.J.; Rose, C.; Reeve, J.; Warburton, E.A. Reduced vitamin D in acute stroke. Stroke, 2006, 37(1), 243-245.
81. Pilz, S.; Dobnig, H.; Fischer, J.E.; Wellnitz, B.; Seelhorst, U.; Boehm, B.O.; Marz, W. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke, 2008, 39, 2611-2613.
82. Mancuso, P.; Rahman, A.; Hershey, S.D.; Dandu, L.; Nibbelink, K.A.; Simpson, R.U. 1,25-dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J. Cardiovasc. Pharmacol., 2008, 51(6), 559-564.
83. Simpson, R.U.; Hershey, S.H.; Nibbelink, K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 521-524.
84. Rhaman, A.; Hershey, S.; Ahmed, S.; Nibbelink, K.; Simpson, R.U. Heart extracellular matrix gene expression profile in the vitamin D receptor knock-out mice. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 416-419.
85. Pilz, S.; Marz, W.; Wellnitz, B.; Seelhorst, U.; Fahrleitner-Pammer, A.; Dimai, H.P.; Boehm, B.O.; Dobnig, H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J. Clin. Endocrinol. Metab., 2008, 93(10), 3927-3935.
86. Zittermann, A.; Schleithoff, S.S.; Gotting, C.; Dronow, O.; Fuchs, U.; Kuhn, J.; Kleesiek, K.; Tenderich, G.; Koerfer, R. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur. J. Heart Fail., 2008, 10(3), 321-327.
87. Zittermann, A.; Fischer, J.; Schleithoff, S.S.; Tenderich, G.; Fuchs, U.; Koerfer, R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int. J. Vitam. Nutr. Res., 2007, 77(4), 280-288.
88. Wang, T.J.; Pencina, M.J.; Booth, S.L.; Jacques, P.F.; Ingelsson, E.; Lanier, K.; Benjamin, E.J.; D'Agostino, R.B.; Wolf, M.; Vasan, R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation, 2008, 117, 503-511.
89. Ginde, A.A.; Scragg, R.; Schwartz, R.S.; Camargo, C.A. Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc., 2009, 57(9), 1595-1603.
90. Pilz, S.; Dobnig, H.; Nijpels, G.; Heine, R.J.; Stehouwer, C.D.; Snijder, M.B.; van Dam R.M.; Dekker, J.M. Vitamin D and mortality in older men and women. Clin. Endocrinol., 2009, 71(5), 666-672.
91. Dobnig, H.; Pilz, S.; Scharnagl, H.; Renner, W.; Seelhorst, U.; Wellnitz, B.; Kinkeldei J.; Boehm, B.O.; Weihrauch, G.; Maerz, W. Independent association of low serum 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med., 2008, 168, 1340-1349.
92. Kunitomo, M.; Kinoshita, K.; Bando, Y. Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet. J. Pharmacobiodyn., 1981, 4, 718-723.
93. Ito, M.; Cho, B.H.; Kummerow, F.A. Effects of a dietary magnesium deficiency and excess vitamin D3 on swine coronary arteries. J. Am. Coll. Nut., 1990, 9, 155-163.
94. Hsia, J.; Heiss, G.; Ren, H.; Allison, M.; Dolan, N.C.; Greenland, P.; Heckbert, S.R.; Johnson, K.C.; Manson, J.E.; Sidney, S.; Trevisan, M.; Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation, 2007, 115, 827-828.
95. Michos, E.D.; Blumenthal, R.S. Vitamin D supplementation and cardiovascular disease risk. Circulation, 2007, 115, 827-828.
96. Bolland, M.J.; Barber, P.A.; Dought, R.N.; Mason, B.; Horne, A.; Ames, R.; Gamble. G.D.; Grey, A.; Reid, I.R. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ, 2008, 336(7638), 262-266.
97. Autier, P.; Gandini, S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med., 2007, 167(16), 1730-1737.
98. Boxer, R.S.; Dauser, D.A.; Walsh, S.J.; Hager, W.D.; Kenny, A.M. The association between vitamin D and inflammation with the 6minute walk and frailty in patients with heart failure. J. Am. Geriatr. Soc., 2008, 56(3), 454-461.
99. Brigham and Women's Hospital: Largest study of vitamin D and omega-3s set to begin soon at Brigham and Women's hospital. Retrieved August 25, 2009, from http://www.brighamandwomens.org/Pressreleases/PressRelease.aspx?PageID=508